1S7

(2R)-2-{(1S)-1-methoxy-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid

Created:	2013-05-15
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 1S7 is found as a standalone ligand5 entries where 1S7 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	2
Bond Count	41
Aromatic Bond Count	5

2D diagram of 1S7

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R)-2-{(1S)-1-methoxy-2-oxo-1-[(thiophen-2-ylacetyl)amino]ethyl}-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Synonyms	Cefoxitin, bound form
Systematic Name (OpenEye OEToolkits)	(2R)-2-[(1S)-1-methoxy-2-oxidanylidene-1-(2-thiophen-2-ylethanoylamino)ethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid
Formula	C₁₅ H₁₆ N₂ O₅ S₂
Molecular Weight	368.428
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=CC(OC)(NC(=O)Cc1sccc1)C2N=C(C(=O)O)\C(=C)CS2
SMILES	CACTVS	3.370	CO[C](NC(=O)Cc1sccc1)(C=O)[CH]2SCC(=C)C(=N2)C(O)=O
SMILES	OpenEye OEToolkits	1.7.6	COC(C=O)(C1N=C(C(=C)CS1)C(=O)O)NC(=O)Cc2cccs2
Canonical SMILES	CACTVS	3.370	CO[C@@](NC(=O)Cc1sccc1)(C=O)[C@H]2SCC(=C)C(=N2)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	CO[C@@](C=O)([C@@H]1N=C(C(=C)CS1)C(=O)O)NC(=O)Cc2cccs2
InChI	InChI	1.03	InChI=1S/C15H16N2O5S2/c1-9-7-24-14(16-12(9)13(20)21)15(8-18,22-2)17-11(19)6-10-4-3-5-23-10/h3-5,8,14H,1,6-7H2,2H3,(H,17,19)(H,20,21)/t14-,15+/m1/s1
InChIKey	InChI	1.03	BMQDZZSQSZJJQV-CABCVRRESA-N

Related Resource References

Resource Name	Reference
PubChem	137347990

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.